METASTATIC LIVER CANCER
Clinical trials for METASTATIC LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC LIVER CANCER trials appear
Sign up with your email to follow new studies for METASTATIC LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental immune cell therapy for liver cancer hits early roadblock
Disease control TerminatedThis early-stage trial tested a new type of immune cell therapy (ET140203 T cells) in 8 adults with advanced liver cancer that had not responded to other treatments. The therapy was designed to target a protein called AFP found on cancer cells. The study was terminated early, so …
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE1 • Sponsor: Eureka Therapeutics Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:13 UTC
-
New device aims to sharpen liver tumor ablation
Knowledge-focused TerminatedThis pilot study tested a device called BioTraceIO 360, designed to help doctors plan and monitor procedures that destroy liver tumors using heat. The study planned to enroll 30 people with liver cancer, but only 4 participated before it was stopped early. Researchers looked at w…
Matched conditions: METASTATIC LIVER CANCER
Phase: NA • Sponsor: Techsomed Medical Technologies LTD • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:06 UTC